logo
Blood Flow Measurement Devices Market to Surpass USD 1,652.1 Million by 2032, Driven by Rising Demand for Non-Invasive Diagnostics

Blood Flow Measurement Devices Market to Surpass USD 1,652.1 Million by 2032, Driven by Rising Demand for Non-Invasive Diagnostics

Yahoo7 hours ago
Burlingame, CA, July 14, 2025 (GLOBE NEWSWIRE) -- The global Blood Flow Measurement Devices Market is estimated to be valued at USD 886.0 Mn in 2025 and is expected to reach USD 1,652.1 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 9.3% from 2025 to 2032. The demand for blood flow measurement devices is projected to rise steadily, driven by several key factors. These include a growing elderly population, an increasing prevalence of cardiovascular diseases, and a rising preference for minimally invasive surgical procedures. Technological advancements particularly in Doppler ultrasound systems are enhancing the accuracy and efficiency of blood flow detection and analysis, further propelling market expansion. However, the high cost of these advanced devices may pose a challenge and potentially limit broader adoption.
Request Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/183
Global Blood Flow Measurement Devices Market Key Takeaways
According to Coherent Market Insights (CMI), the global blood flow measurement devices market size is expected to grow significantly during the forecast period, reaching USD 886 Mn in 2025 and USD 1,652.1 Mn by 2032.
Global demand for blood flow measurement devices is projected to increase at a CAGR of 9.3% between 2025 and 2032.
Laser Doppler blood flowmeters are expected to remain the top-selling product type, generating market revenue of about USD 314.5 Mn in 2025.
Based on application, cardiovascular disease segment is expected to account for 45.5% of the global blood flow measurement devices market share in 2025.
North America is set to remain the undisputed leader in the blood flow measurement devices industry, accounting for more than two-fifths of the global market share in 2025
Asia Pacific is expected to emerge as a hotbed for blood flood measurement device manufacturers during the assessment period. This is due to rising incidence of cardiovascular diseases and favorable government support.
Rising Chronic Disease Burden Spurring Market Growth
Coherent Market Insights' latest blood flow measurement devices market analysis offers insights into major factors driving industry growth. One such prominent growth driver is the increasing incidence of chronic diseases.
Growing prevalence of cardiovascular and peripheral vascular diseases like atherosclerosis and hypertension is significantly driving demand for blood flow measurement devices. These devices enable real-time monitoring of blood circulation, which is essential for early detection, diagnosis, and timely medical intervention.
Immediate Delivery Available | Buy This Premium Research Report: https://www.coherentmarketinsights.com/insight/buy-now/183
High Cost of Advanced Devices Limiting Market Growth
The future blood flow measurement devices market outlook appears optimistic. However, high cost of advanced blood flow measurement devices is a significant barrier to widespread market expansion.
Cutting-edge blood flow measurement systems like Doppler and electromagnetic flowmeters are quite expensive. This high cost deters small and medium-sized hospitals and clinics from adopting these technologies, leading to reduced overall blood flow measurement devices market demand.
Rising Preference for Non-Invasive Diagnostic Tools Creating Growth Opportunities
There is a growing preference for non-invasive and painless methods for measuring blood flow in the modern world. This is expected to uplift demand for advanced blood flow measurement devices, opening lucrative growth prospects for industry players.
Increasing geriatric population is also creating growth opportunities for manufacturers of blood flow measurement devices. This is because elderly people are more susceptible to vascular disorders and diabetes, which require blood flow assessments.
Impact of AI on the Blood Flow Measurement Devices Market
Artificial Intelligence (AI) is becoming a powerful tool in the blood flow measurement devices market. It significantly enhances diagnostic precision, enables real-time monitoring, and expands these tools into wearable and telehealth applications.
Advanced analytics powered by AI and machine learning help detect subtle changes in blood flow that human observers might miss. This results in improved accuracy and predictiveness.
IoT and cloud integration enable remote monitoring and timely clinician alerts for vascular issues. Key players are developing smart ultrasound and PPG systems with edge AI for cuffless, low-power measurements in wearables and point-of-care devices.
Emerging Blood Flow Measurement Devices Market Trends
Technological advancements in blood flow measurement systems are breathing new life into the market. Companies are constantly developing advanced Doppler ultrasound and electromagnetic blood flowmeters to improve accuracy, sensitivity, and efficiency of diagnostic procedures.
Portable and wearable blood flow measurement devices are gaining immense traction in clinical and homecare settings. Rising adoption of these compact and user-friendly solutions is expected to foster growth of the blood flow measurement devices market in the coming years.
Increasing number of surgical and diagnostic procedures is also contributing to rising sales of blood flow measurement devices. These devices are being widely used for blood flow monitoring during vascular surgeries, organ transplants, and reconstructive procedures for better outcomes.
Growing number of surgical and diagnostic procedures is contributing to rising sales of blood flow measurement devices. These devices are increasingly used during vascular surgeries, organ transplants, and reconstructive procedures to monitor blood flow and ensure optimal patient outcomes.
Request for Customization: https://www.coherentmarketinsights.com/insight/request-customization/183
Analyst's View
said senior analyst Komal Dighe.
Current Events and Their Impact on the Blood Flow Measurement Devices Market
Event
Description and Impact
Rising Cardiovascular Complications Linked to Long COVID and Post-COVID Conditions
Description: Recent studies highlight a significant increase in vascular complications in post-COVID patients, especially microvascular dysfunction.
Impact: This is pushing hospitals and research centers to invest in advanced blood flow measurement tools like laser Doppler and perfusion imaging to track subtle circulatory anomalies in recovering patients.
AI Integration in Hemodynamic Monitoring Devices
Description: Leading blood flow measurement device companies are launching AI-enabled Doppler and transit-time flow meters that automatically interpret flow data and flag anomalies in real time.
Impact: These innovations are reducing clinician burden and enhancing early diagnosis, leading to faster adoption in both high-end hospitals and outpatient care settings.
Regulatory Approvals and Reimbursements
Description: Recent FDA and CE approvals for innovative blood flow measurement systems (e.g., laser Doppler flowmetry, transit-time flow meters) improve market trust.
Impact: Such approvals strengthen commercialization prospects and encourage new product launches by key market players.
Competitor InsightsKey companies listed in the blood flow measurement devices market report include:
Medistim ASA
Cook Medical Inc.
Perimed AB
Transonic Systems Inc.
Atys Medical
Getinge Group
Deltex Medical Group PLC
Biopac Systems Inc.
ADInstruments
Fluke Biomedical
Compumedics
Moor Instruments Ltd.
ArjoHuntleigh Inc.
SONOTEC GmbH
NDS Surgical Imaging
Cheetah Medical
Koven Technology
D.E. Hokie & Associates
Nihon Kohden Corporation
GSI Group
Key Developments
In July 2024, Getinge introduced Pulsiocare, a cutting-edge hemodynamic monitoring platform built on its award-winning standard user interface. The new advanced device offers a modern and intuitive-to-use platform for hemodynamic assessment and patient monitoring.
In October 2024, Researchers at the California Institute created a laser-based, head‑worn device that noninvasively monitors cerebral blood flow and volume using speckle contrast optical spectroscopy (SCOS). This novel device offers a direct method of assessing stroke risk based on physiological markers.
Market Segmentation:
By Product Type
Laser Doppler Blood Flowmeters
Ultrasonic Doppler Blood Flowmeters
Electromagnetic Blood Flowmeters
By Application
Cardiovascular Disease
Tumor Monitoring
Gastroenterology
Diabetes
Dermatology
Others
By End User
Hospital
Clinics
Ambulatory Surgical Centers
Specialty Centers
Others
Region:
North America
Europe
Asia Pacific
Latin America
Middle East
Africa
Read More Report:Blood Clot Retrieval Devices Market Analysis and Forecast for 2025-2032Blood Glucose Monitoring Market Size, Share & Trend Analysis Report for 2025-2032Blood Pressure Monitoring Devices Market Size, Share, Trends & Opportunities for 2025-2032
Our Trusted Partners:Worldwide Market Reports, Coherent MI, Stratagem Market InsightsGet Recent News:https://www.coherentmarketinsights.com/news
CONTACT: About Us: Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries. Contact Us: Mr. Shah Coherent Market Insights 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States US: + 12524771362 UK: +442039578553 AUS: +61-2-4786-0457 India: +91-848-285-0837 Email: sales@coherentmarketinsights.com Website: https://www.coherentmarketinsights.com For Latest Update Follow Us: LinkedIn | Facebook | Twitter
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

How Florida became America's leading religious-freedom defender under DeSantis: report
How Florida became America's leading religious-freedom defender under DeSantis: report

Fox News

time29 minutes ago

  • Fox News

How Florida became America's leading religious-freedom defender under DeSantis: report

The Sunshine State ranks as the nation's number one defender of religious liberty out of all 50 states, according to the First Liberty Institute's fourth annual Religious Liberty in the States (RLS) index. For the first time, Florida tops the national rankings, followed by Montana, Illinois, Ohio and Mississippi. Illinois and Mississippi have garnered a spot in the top five every year since the index was first released by the First Liberty Institute's Center for Religion, Culture & Democracy (CRCD) in 2022. The index uses a detailed scoring system measuring legal protections and ranking states based on the percentage of possible safeguards they have adopted. This year, with 2025's rankings, nearly 55 percentage points separates Florida from the last-place state, West Virginia, which has been last on the index for three years in a row. "We find that the states are laboratories of religious liberty where different protections for free exercise can be implemented and tested," CRCD Executive Director Jordan Ballor wrote in an introduction for the 2025 index. "One of the major goals of the RLS project is to raise awareness of what different states are doing. There are positive lessons to be learned from this experimentation, as states that have been at the vanguard of protecting religious liberty can serve as exemplars for states that have lagged behind." The index's accompanying report points out that Florida "is an exemplar" for how state lawmakers can improve their protections around religious freedom. According to the report, the Sunshine State has improved nearly 20 percentage points since the first RLS index was released in 2022. Much of this improvement came from legislation passed in 2023 strengthening religious protections that allow healthcare providers to refuse to participate in medical procedures or services, such as abortion or sterilization, based on their religious or moral beliefs. The report also pointed to Florida's passage of legislation in 2022 protecting houses of worship from discriminatory treatment during pandemics and other emergencies. "Florida holds several #1 rankings, leading the nation in education, economy, and tourism – and now, Florida is #1 in religious liberty," said Florida Gov. Ron DeSantis. "We're grateful for this recognition from the First Liberty Institute, which has just named Florida the number one state in the nation for protecting religious liberty." "This year's findings show clearly that states taking legislative action are pulling ahead," added Kelly Shackelford, president, CEO and chief counsel at First Liberty. "Under the leadership of Gov. DeSantis, Florida passed real laws that protect real people, and now the Sunshine State is the national leader in protecting religious liberty. It's time for more states to follow Gov. DeSantis's example and adopt strong religious liberty laws." While Florida was pointed to in the RLS index as an "exemplar," the report stated that religious freedom was becoming increasingly "tenuous" in the blue state of Illinois. The move downward for the Land of Lincoln was not because the state repealed protections, but mainly because it has not implemented new protections that other states, like Florida, have, the report noted. Per the 2025 RLS report, almost all of Illinois' protections came when the state was more conservative between 1934 and 1998. In an effort to demonstrate the dangers of "complacency," the report also pointed to Colorado when Republicans "routinely" had control of both houses of the state legislature. The environment was friendly toward religious liberty, but lawmakers did not pass much in the way of protections, according to the report. It said the state's complacency contributed to Colorado's "abysmal" 43rd-place finish in the 2024 RLS rankings and 34th finish in the 2025 rankings released Monday. The First Liberty Institute said the results of the 2024 election may give some people the idea that passing laws protecting religious liberty is not as important, but the conservative Christian legal group warned this is "emphatically not the case," noting that data shows passing such laws is just as critical amid a "favorable" political climate.

The FDA Just Approved a New Blue Food Dye: This Is What It's Made Of
The FDA Just Approved a New Blue Food Dye: This Is What It's Made Of

CNET

time34 minutes ago

  • CNET

The FDA Just Approved a New Blue Food Dye: This Is What It's Made Of

This year, food dyes are being put under a microscope. Following the FDA ban on Red Dye No. 3 in January, the administration has since approved three natural food dyes in its stead. Now, in addition to the FDA and Department of Health and Human Services asking food manufacturers to phase out all petroleum-based synthetic dyes from the US food supply, the FDA is asking these companies to fast-track getting rid of Red No. 3 before the 2027 deadline. To help this along, the administration just approved a new blue food dye. As the fourth color additive from natural sources approved by the FDA this year, gardenia (genipin) blue has been granted permission to be used in various foods. According to the administration, this blue dye comes from the fruit of the gardenia, a flowering evergreen. It can be used in hard and soft candy, sports drinks, ready-to-drink teas, flavored or enhanced non-carbonated water and fruit drinks and ades. "This expedited timeline underscored our serious intent to transition away from petroleum-based synthetic dyes in the food supply, said FDA Commissioner Marty Makary in a news release. "Now, by expanding the palette of available colors derived from natural sources, food manufacturers have a variety of options available that will make it easier to end their use of petroleum-based dyes." Gardenia (genipin) blue joins the red algae-based galdieria extract blue, butterfly pea flower extract and the white color calcium phosphate as 2025's new and approved natural food color additives. MichelleHow is gardenia (genipin) blue made? The FDA approved the use of gardenia (genipin) blue from a petition by the Gardenia Blue Interest Group (GBIG). According to the FDA's order, gardenia (genipin) blue is a dark purple or blue liquid made from the mature fruit of the Gardenia jasminoides Ellis plant with soy protein hydrolysate. Now, you may be thinking: Isn't soy an allergen? According to the GBIG, the soy protein allergens aren't expected to be detected in the final color additive because "unreacted protein hydrolysate is removed during manufacturing." Because no soy protein allergens will be in the final product, the GBIG is asking to be exempt from food allergen labeling. The FDA is currently reviewing this petition.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store